trial · primary record
TAK-861
Narcolepsy Type 1 (NT1)
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 98 |
| Primary completion | 2026-12-17 |
| Primary endpoint | Time to Loss of Response in the Epworth Sleepiness Scale (ESS) Score During the Up to 4-Week RW Period |
| Registry ID | NCT07363720 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:13.849Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07363720
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.